Segui
Christopher Howard
Titolo
Citata da
Citata da
Anno
Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production
BJ Johnson, TTT Le, CA Dobbin, T Banovic, CB Howard, FML Flores, ...
Journal of Biological Chemistry 280 (6), 4037-4047, 2005
1842005
Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP
J Mo, JP Boyle, CB Howard, TP Monie, BK Davis, JA Duncan
Journal of Biological Chemistry 287 (27), 23057-23067, 2012
1822012
Recent advances in the generation of antibody–nanomaterial conjugates
AJ Sivaram, A Wardiana, CB Howard, SM Mahler, KJ Thurecht
Advanced healthcare materials 7 (1), 1700607, 2018
1092018
Targeting membrane proteins for antibody discovery using phage display
ML Jones, MA Alfaleh, S Kumble, S Zhang, GW Osborne, M Yeh, N Arora, ...
Scientific reports 6 (1), 26240, 2016
952016
Preparation of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cells
J Tang, L Li, CB Howard, SM Mahler, L Huang, ZP Xu
Journal of materials chemistry B 3 (33), 6805-6812, 2015
902015
Targeted camptothecin delivery via silicon nanoparticles reduces breast cancer metastasis
M Landgraf, CA Lahr, I Kaur, A Shafiee, A Sanchez-Herrero, PW Janowicz, ...
Biomaterials 240, 119791, 2020
862020
Identification and Minisequencing-Based Discrimination of SHV β-Lactamases in Nosocomial Infection-Associated Klebsiella pneumoniae in Brisbane, Australia
C Howard, A Van Daal, G Kelly, J Schooneveldt, G Nimmo, PM Giffard
Antimicrobial agents and chemotherapy 46 (3), 659-664, 2002
802002
Enhanced uptake of potassium or glycine betaine or export of cyclic-di-AMP restores osmoresistance in a high cyclic-di-AMP Lactococcus lactis mutant
HT Pham, NTH Nhiep, TNM Vu, TAN Huynh, Y Zhu, ALD Huynh, ...
PLoS genetics 14 (8), e1007574, 2018
732018
Multiplexed SERS detection of soluble cancer protein biomarkers with gold–silver alloy nanoboxes and nanoyeast single-chain variable fragments
J Li, J Wang, YS Grewal, CB Howard, LJ Raftery, S Mahler, Y Wang, ...
Analytical chemistry 90 (17), 10377-10384, 2018
712018
Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands
J Tang, CB Howard, SM Mahler, KJ Thurecht, L Huang, ZP Xu
Nanoscale 10 (9), 4258-4266, 2018
702018
Overcoming instability of antibody‐nanomaterial conjugates: next generation targeted nanomedicines using bispecific antibodies
CB Howard, N Fletcher, ZH Houston, AV Fuchs, NRB Boase, JD Simpson, ...
Advanced healthcare materials 5 (16), 2055-2068, 2016
622016
A SERS microfluidic platform for targeting multiple soluble immune checkpoints
KK Reza, AAI Sina, A Wuethrich, YS Grewal, CB Howard, D Korbie, ...
Biosensors and Bioelectronics 126, 178-186, 2019
552019
Strategies for selecting membrane protein-specific antibodies using phage display with cell-based panning
MA Alfaleh, ML Jones, CB Howard, SM Mahler
Antibodies 6 (3), 10, 2017
482017
Nanocell targeting using engineered bispecific antibodies
K Taylor, CB Howard, ML Jones, I Sedliarou, J MacDiarmid, H Brahmbhatt, ...
MAbs 7 (1), 53-65, 2015
432015
Understanding the uptake of nanomedicines at different stages of brain cancer using a modular nanocarrier platform and precision bispecific antibodies
ZH Houston, J Bunt, KS Chen, S Puttick, CB Howard, NL Fletcher, ...
ACS central science 6 (5), 727-738, 2020
422020
Modulating targeting of poly (ethylene glycol) particles to tumor cells using bispecific antibodies
J Cui, Y Ju, ZH Houston, JJ Glass, NL Fletcher, S Alcantara, Q Dai, ...
Advanced healthcare materials 8 (9), 1801607, 2019
422019
Controlling the biological fate of micellar nanoparticles: Balancing stealth and targeting
AJ Sivaram, A Wardiana, S Alcantara, SE Sonderegger, NL Fletcher, ...
ACS nano 14 (10), 13739-13753, 2020
352020
Multifunctional lipid-coated calcium phosphate nanoplatforms for complete inhibition of large triple negative breast cancer via targeted combined therapy
J Tang, B Li, CB Howard, SM Mahler, KJ Thurecht, Y Wu, L Huang, ZP Xu
Biomaterials 216, 119232, 2019
292019
Targeting the undruggable: emerging technologies in antibody delivery against intracellular targets
S Niamsuphap, C Fercher, S Kumble, P Huda, SM Mahler, CB Howard
Expert Opinion on Drug Delivery 17 (9), 1189-1211, 2020
272020
Bispecific antibody-functionalized upconversion nanoprobe
H He, CB Howard, Y Chen, S Wen, G Lin, J Zhou, KJ Thurecht, D Jin
Analytical chemistry 90 (5), 3024-3029, 2018
272018
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20